Real-world experience with hypomethylating agents and venetoclax as induction or salvage therapy followed by allogeneic stem cell transplantation in patients with acute myeloid leukemia

被引：0
|
作者：
Rautenberg, C. [1 ]
Stelljes, M. [2 ]
Acker, F. [3 ]
Holtick, U. [4 ]
Jost, E. [5 ]
Ragette, A. [1 ]
Kaivers, J. [1 ]
Tischer, J. [6 ]
Fraccaroli, A. [6 ]
Neuendor, N. [1 ]
Hanoun, M. [1 ]
Schmalbrock, L. K. [7 ]
Braitsch, K. [8 ]
Verbeek, M. [8 ]
Goetze, K. [8 ]
Bug, G. [3 ]
Reinhardt, C. [1 ]
Kroeger, N. [9 ]
Schroeder, T. [1 ]
机构：
[1] Uniklin Essen, Klin Hamatol & Stammzelltransplantat, Essen, Germany
[2] Uniklin Munster, Munster, Germany
[3] Uniklin Frankfurt, Frankfurt, Germany
[4] Uniklin Koln, Cologne, Germany
[5] Uniklin Aachen, Aachen, Germany
[6] LMU Munchen, Munich, Germany
[7] Charite Univ Med Berlin, Dept Hematol Oncol & Canc Immunol, Campus Benjamin Franklin, Berlin, Germany
[8] Klinikum Rechts Der Isar, Munich, Germany
[9] Uniklin Hamburg Eppendorf, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P369
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [31] Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation
    Qingya Wang
    Zeyin Liang
    Hanyun Ren
    Yujun Dong
    Yue Yin
    Qingyun Wang
    Wei Liu
    Bingjie Wang
    Na Han
    Yangliu Li
    Yuan Li
    Annals of Hematology, 2023, 102 : 3061 - 3074
  • [32] Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation
    Wang, Qingya
    Liang, Zeyin
    Ren, Hanyun
    Dong, Yujun
    Yin, Yue
    Wang, Qingyun
    Liu, Wei
    Wang, Bingjie
    Han, Na
    Li, Yangliu
    Li, Yuan
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3061 - 3074
  • [33] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Andrius Zucenka
    Vilmante Vaitekenaite
    Kazimieras Maneikis
    Linas Davainis
    Regina Pileckyte
    Igoris Trociukas
    Valdas Peceliunas
    Tadas Zvirblis
    Vytautas Staras
    Laimonas Griskevicius
    Bone Marrow Transplantation, 2021, 56 : 2804 - 2812
  • [34] Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
    Zucenka, Andrius
    Vaitekenaite, Vilmante
    Maneikis, Kazimieras
    Davainis, Linas
    Pileckyte, Regina
    Trociukas, Igoris
    Peceliunas, Valdas
    Zvirblis, Tadas
    Staras, Vytautas
    Griskevicius, Laimonas
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2804 - 2812
  • [35] Real-world treatment patterns of venetoclax and azacytidine therapy in Japanese patients with acute myeloid leukemia
    Gando, Yoshito
    Yasu, Takeo
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1283 - 1285
  • [36] Real-world treatment patterns of venetoclax and azacytidine therapy in Japanese patients with acute myeloid leukemia
    Yoshito Gando
    Takeo Yasu
    Annals of Hematology, 2023, 102 : 1283 - 1285
  • [37] Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts
    Gangat, Naseema
    McCullough, Kristen
    Johnson, Isla
    Al-Kali, Aref
    Begna, Kebede H.
    Patnaik, Mrinal M.
    Litzow, Mark R.
    Hogan, William
    Shah, Mithun
    Alkhateeb, Hassan
    Mangaonkar, Abhishek
    Foran, James M.
    Badar, Talha
    Palmer, Jeanne M.
    Sproat, Lisa
    Arana Yi, Cecilia Y.
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : E214 - E216
  • [38] Real-world experience with isavuconazole in allogeneic stem cell transplantation
    Oarbeascoa, G.
    Torres, M.
    Martinez, A. Perez
    Suarez-Lledo, M.
    Chinea, A.
    Cascon, M. J. Pascual
    Vazquez, L.
    Espigado, I.
    Izquierdo, I.
    Parody, R.
    Cadenas, I. Garcia
    Calbacho, M.
    Sierra, P. Gonzalez
    Heras, I.
    Yanez, L.
    Torrent, A.
    Bautista, G.
    Gonzalez, S.
    Roldan, E.
    Vallejo, J. C.
    Bailen, R.
    Borrego, A.
    Lopez-Jimenez, J.
    Casas, M. Cuesta
    Solano, C.
    Kwon, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 271 - 272
  • [39] Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse
    Serpenti, Fabio
    Sciume, Mariarita
    Galassi, Giulia
    Saporiti, Giorgia
    Grifoni, Federica
    Rampi, Nicolo
    Cavallaro, Francesca
    Barbullushi, Kordelia
    Tagliaferri, Elena
    Goldaniga, Maria
    Baldini, Luca
    Fracchiolla, Nicola Stefano
    Onida, Francesco
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2743 - 2746
  • [40] Outcomes of Acute Myeloid Leukemia Relapsed Post-Allogeneic Hematopoietic Stem Cell Transplant Treated with Hypomethylating Agents and Venetoclax Combination: A Single Center Experience
    Ionescu, Filip
    Sallman, David A.
    Sweet, Kendra
    Komrokji, Rami S.
    Chan, Onyee
    Kuykendall, Andrew
    Padron, Eric
    Faramand, Rawan
    Bejanyan, Nelli
    Khimani, Farhad
    Elmariah, Hany
    Pidala, Joseph
    Mishra, Asmita
    Perez, Lia
    Nishihori, Taiga
    Lancet, Jeffrey E.
    BLOOD, 2022, 140 : 1288 - 1290
12345